Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

PHASE1

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped The trial prematurely terminated on November 1, 2010, due to healthy volunteer participants experiencing non-serious fosamprenavir-related skin rash.

Conditions

Healthy

Interventions

DRUG: Maraviroc
DRUG: Fosamprenavir/ritonavir
DRUG: Maraviroc + Fosamprenavir/ritonavir
DRUG: Maraviroc
DRUG: Fosamprenavir/ritonavir
DRUG: Maraviroc + Fosamprenavir/ritonavir

Sponsor

ViiV Healthcare

Collaborators

[object Object]